The biopharmaceutical patient support landscape is rapidly transforming day by day.
Our 2024 industry survey captured a vital snapshot of the industry, and over the past two years, we haven't just measured changes; we've actively applied our expertise, supporting manufacturers in real-time through critical shifts in hub models.
Now, our 2026 benchmark report brings it all together. Drawing on data from 200 biopharmaceutical manufacturers and years of hands-on experience, this report compares where the industry stood in 2024 with where it is today — revealing how priorities have shifted, where challenges remain and what leading manufacturers are doing differently.
Inside the report, you’ll uncover:
- Key trends reshaping patient support programs
- How manufacturers have adapted hub models the past two years
- Evolving expectations for technology, solutions and vendor relationships
- Actionable insights to help you plan what’s next with confidence
Download the 2026 benchmark report to see how patient support has evolved, and what it means for your organization.